Physical activity before and during pregnancy and risk of gestational diabetes mellitus: a meta-analysis

Deirdre K Tobias1, Cuilin Zhang, Rob M van Dam

  • 1Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA. dbanel@hsph.harvard.edu

Diabetes Care
|September 30, 2010
PubMed

Insights

Engaging in regular physical activity before or during early pregnancy significantly lowers the risk of developing gestational diabetes mellitus (GDM). This finding highlights the importance of exercise for maternal health during pregnancy.

Area of Science:

  • Obstetrics and Gynecology
  • Public Health
  • Exercise Science

Background:

  • Gestational diabetes mellitus (GDM) is a common pregnancy complication.
  • GDM increases risks for mothers and offspring, contributing to obesity and diabetes.
  • Physical activity is a potential preventative measure against GDM.

Purpose of the Study:

  • To systematically review and synthesize evidence on physical activity and GDM development.
  • To understand the relationship between exercise and GDM risk.

Main Methods:

  • Searched Medline, EMBASE, and Cochrane Reviews up to March 2010.
  • Included studies on physical activity and subsequent GDM development.
  • Extracted data on study design, GDM criteria, physical activity assessment, and timing of exposure.

Main Results:

  • Included 12 studies (7 prepregnancy, 5 early pregnancy).
  • Higher prepregnancy physical activity showed a pooled odds ratio of 0.45 (95% CI 0.28-0.75) for GDM.
  • Exercise in early pregnancy was also protective, with an odds ratio of 0.76 (95% CI 0.70-0.83).

Conclusions:

  • Increased physical activity before pregnancy is linked to lower GDM risk.
  • Physical activity during early pregnancy also reduces the likelihood of developing GDM.
  • Exercise is a key factor in preventing GDM and mitigating associated health risks.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...